Table 1 Epidemiologic and clinic chracteristics of the population according to the sex and the management sector

N

25,890

14,166

11,700

20,192

5698

Age (years)

Median (min–max)

Mean ± SD

64.00 (18–118)

64.4 ± 12.2

64 (18–118)

64.5 ± 12.2

64 (18–108)

64.2 ± 12.2

0.059*

64 (18–118)

64.46 ± 12.2

65 (18–101)

64.19 ± 12.1

0.4

Age > 65 yo (%)

12,662 (49.3)

6982 (49.7)

5673 (48.8)

0.1

9860 (49.1)

2802 (50.1)

0.4

Ramadan Inclusion (%)

16,565 (64)

9155 (64.6)

7403 (63.3)

0.02

13,173 (35.2)

3392 (59.5)

 < 10^–3

Education level

Illiterate (%)

Primary school (%)

Secondary school (%)

University school (%)

Unspecified (%)

5527 (21.3)

5475 (21.1)

4493 (17.4)

2428 (9.4)

7967 (30.8)

4261 (30.1)

3124 (22.1)

1880 (13.3)

825 (5.8)

4076 (28.8)

1262 (10.8)

2346 (20.1)

2612 (22.3)

1600 (13.7)

3880 (33.2)

< 10^–3

4527 (22.4)

4384 (21.7)

3139 (15.5)

1439 (7.1)

6703 (33.2)

1000 (17.6)

1091 (19.1)

1354 (23.8)

989 (17.4)

1264 (22.2)

 < 10^–3

Health insurance coverage

Private insurance (%)

National insurance (%)

State Medicare (%)

None insurance (%)

Unspecified (%)

762 (2.9)

18,453 (71.3)

5052 (19.5)

790 (3.1)

833 (3.2)

399 (2.8)

9806 (69.2)

3114 (22)

408 (2.9)

439 (3.1)

363 (3.1)

8632 (73.8)

1936 (16.5)

382 (3.3)

387 (3.3)

< 10^–3

434 (2.1)

14,165 (70.2)

4724 (23.4)

520 (2.6)

346 (1.7)

328 (5.8)

4285 (75.2)

328 (5.8)

270 (4.7)

487 (8.5)

 < 10^–3

Smoking (%)

3630 (14)

391 (2.8)

3236 (27.7)

 < 10^–3

3021 (15)

609 (10.7)

 < 10^–3

Diabetes (%)

10,204 (39.4)

5621 (39.7)

4583 (39.2)

0.4

8185 (40.5)

2029 (35.6)

 < 10^–3

Obesity (%)

6979 (25.8)

4927 (34.7)

2065 (17.6)

 < 10^–3

5207 ( 25.9)

2590 (46.3)

 < 10^–3

Corpulence

Overweight (%)

Moderate obesity (%)

morbid Obesity (%)

severe Obesity (%)

11,539 (44.6)

5182 (20)

461 (1.8)

1354 (5.2)

5984 (42.2)

3509 (24.8)

375 (2.6)

1043 (7.4)

5546 (47.4)

1671 (14.3)

85 (0.7)

310 (2.6)

 < 10–3

9454 (46.8)

3946 (19.5)

302 (1.5)

959 (4.7)

2085 (36.6)

1236 (21.7)

959 (2.8)

395 (6.9)

 < 10^–3

BMI (kg/cm²)

Median (min–max)

Mean ± SD

27.5 (13.7–72.2)

28.1 ± 4.57

28.3 (14–70)

29.01 ± 4.57

27.07 ± 3.93

 < 10^–3*

27.3 (14–72)

27.9 ± 4.3

29 (13.7–66.9)

29.08 ± 5.13

 < 10^–3*

Newly diagnosed HTN (%)

1475 (5.7)

705 (5.1)

770 (6.8)

 < 10^–3

953 (4.7)

522 (9.2)

 < 10^–3

Moderate Renal Failure (%)

1524 (5.9)

672 (4.7)

851 (7.3)

 < 10^–3

1305 (6.5)

219 (3.8)

 < 10^–3

Hypothyroidism (%)

1384 (5.3)

1136 (8)

248 (2.1)

 < 10^–3

1034 (5.1)

350 (6.1)

0.002

Apnea syndrome

Confirmed (%)

Suspected (%)

469 (1.8)

843 (3.3)

257 (1.8)

499 (3.5)

211 (1.8)

343 (2.9)

0.02

276 (1.4)

505 (2.5)

193 (3.4)

338 (5.9)

 < 10^–3

COPD (%)

519 (2)

137 (1)

382 (3.3)

 < 10^–3

380 (1.9)

139 (2.4)

0.008

Stroke history (%)

1707 (6.6)

796 (5.6)

910 (7.8)

 < 10^–3

1311 (6.5)

396 (6.9)

0.2

Coronary disease (%)

4797 (18.5)

1742 (12.3)

3048 (26.1)

 < 10^–3

3941 (19.8)

856 (15)

 < 10^–3

SBP (mmHg)

Median ( min–max)

Mean ± SD

135 (80–260)

138.8 ± 19.6

135 (80–260)

138.5 ± 19.7

140 (85–250)

139.2 ± 19.4

 < 10^–3*

140 (80–260)

138.9 ± 19.7

134.5 (80–260)

138.6 ± 19

0.1*

DBP (mmHg)

Median ( min–max)

Mean ± SD

80 (40–140)

79.03 ± 11.1

80 (40–140)

78.8 ± 10.9

80 (40–140)

79.3 ± 11.3

0.005*

80 (40–140)

78.9 ± 11.2

80 (40–140)

79.4 ± 10.7

0.6*

HTN History > 6 months

23,601 (91.1)

13,058 (55.3)

10,543 (44.7)

 < 10^–3

18,613 (95.1)

4988 (90.5)

 < 10^–3

Controlled HTN

(Target < 140/90 mmHg) (%)

12,206 (51.7)

6825 (52.4)

5371 (50.9)

0.032

9361 (50.3)

2845 (57)

 < 10^–3

Controlled HTN (Target < 130/80 mmHg) (%)

4386 (18.6%)

2486 (19.1)

1896 (18)

0.033

3357 (18)

1029 (20.6)

 < 10^–3

Heart rate (bpm)

Median ( min–max)

Mean ± SD

74 (40–150)

73.8 ± 11

74 (40–150)

74.1 ± 11.1

73 (40–150)

73.5 ± 10.9

 < 10^–3*

74 (40–150)

74.3 ± 10.8

70 (40–150)

72.2 ± 11.8

 < 10^–3

Heart rate > 80 bpm (%)

4878 (19.2)

2754 (19.8)

2120 (18.5)

0.009

3895 (19.6)

983 (17.8)

0.003

LVH on EKG or TTE (%)

3377 (13)

1399 (9.9)

1482 (12.7)

 < 10^–3

2125 (10.5)

758 (13.3)

 < 10^–3

Atrial fibrillation (%)

1914 (7.4)

1130 (8)

783 (6.7)

 < 10^–3

1527 (7.6)

387 (6.8)

0.05

Recent lab tests < 6 months

14,737 (56.9)

8202 (57.9)

6521 (55.7)

 < 10^–3

10,302 (77.8)

4435 (51)

 < 10^–3

Fasting Glucose (g/l)

Median ( min–max)

Mean ± SD

1.1 (0.5–3.9)

1.3 ± 0.5

1.15 (0.6–3.97)

1.8 ± 6.1

1.1 (0.6–3.9)

1.6 ± 3.7

0.8*

1.129 (0.6–3.9)

1.6 ± 2.5

1.1 (0.6–3.8)

1.9 ± 7.6

 < 10^–3*

Creatinine (µmol/l)

Median ( min–max)

Mean ± SD)

81 (30–700)

92.6 ± 50.7

76 (30–681)

85 ± 45.5

89 (32–700)

102 ± 55.11

 < 10^–3*

80 (30–700)

93.1 ± 53.7

85 (30–663)

90.5 ± 38.5

 < 10^–3*

Creatinine clearance (ml/min)

Median (min–max)

Mean ± SD

88.4 (7–287)

90.4 ± 33.5

96.4 (7.62–287.3)

98.5 ± 35.3

79.7 (7.3–246)

80.3 ± 28

< 10^–3*

89.2 (7.3–287)

91 ± 34.6

85 (7.8–262)

88 ± 29

 < 10^–3*

Total Cholesterol (g/l)

Median (min–max)

Mean ± SD

1.8 (1–5)

1.9 ± 0.6

1.8 (1–5)

1.96 ± 0.6

1.7 (1–5)

1.84 ± 0.6

 < 10^–3*

1.8 (1–5)

1.8 ± 0.4

1.8 (1–5)

1.9 ± 0.7

0.6*

K+ (mmol/l)

Median (min–max)

Mean ± SD

4.1 (2.4–7)

4.1 ± 0.4

4.1 (2.5–6.8)

4.15 ± 0.4

4.1 (2.4–7)

4.1 ± 0.4

 < 10^–3*

4.1 (2.45–7)

4.1 ± 0.48

4.1 (2.5–6.8)

4.1 ± 0.42

0.005

Microalbuminuria test during the last year (%)

4042 (15.6)

2226 (15.7)

1814 (15.5)

0.6

2190 (10.8)

1852 (32.5)

 < 10^–3

Positive Microalbuminuria (% among people who got the test)

1365 (33.8)

652 (29.3)

713 (39.3)

 < 10^–3*

910 (41.6)

455 (24.61)

 < 10^–3

Drug treatment

No drug (%)

Monotherapy (%)

Biotherapy (%)

tritherapy or more (%)

4037 (15.6)

12,042 (46.5)

6614 (25.5)

3197 (12.3)

2170 (15.3)

6626 (46.8)

3646 (25.7)

1724 (12.2)

1862 (15.9)

5408 (46.2)

2961 (25.3)

1469 (12.6)

0.3

3032 (15)

9794 (48.5)

5032 (24.9)

2334 (11.6)

1005 (17.6)

2248 (39.5)

1582 (27.8)

863 (15.1)

 < 10^–3

Antihypertensive drugs

ACE (%)

11,770 (45.5)

6420 (45.3)

5341 (45.6)

0.5

9251 (45.8)

2519 (44.2)

0.03

ARB (%)

5587 (20.6)

3012 (21.3)

2569 (22)

0.17

3156 (15.6)

2431 (42.7)

 < 10^–3

CCB (%)

8028 (31.0)

4392 (31)

3630 (31)

0.9

6306 (31.2)

1722 (30.2)

0.14

Diuretics (%)

5514 (21.3)

3061 (21.6)

2446 (20.9)

0.17

4304 (21.3)

1210 (21.2)

0.8

Betablockers (%)

5734 (22.1)

3172 (22.4)

2554 (21.8)

0.27

4445 (22)

1289 (22.6)

0.3

Salt restriction (%)

13,891 (53.7)

7837 (55.3)

6043 (51.6)

 < 10^–3

10,789 (53.4)

3102 (54.4)

0.1

ABPM (%)

656 (2.5)

352 (2.5)

304 (2.6)

0.5

314 (1.6)

342 (6)

 < 10^–3

SMBP (%)

1630 (6.3)

868 (6.1)

762 (6.5)

0.2

1053 (4.1)

577 (10.1)

 < 10^–3

Drug compliance (%)

19,539 (75.5)

10,874 (76.8)

8651 (73.9)

 < 10^–3

15,326 (75.9)

4213 (73.9)

0.002

Physical activity (%)

3845 (14.9)

1598 (11.3)

2243 (19.2)

 < 10^–3

2748 (13.6)

1097 (19.3)

 < 10^–3